DHAI (DIH Holding US) ROE % Adjusted to Book Value: 0.00% (As of Mar. 2025)


What is DIH Holding US ROE % Adjusted to Book Value?

DIH Holding US DHAI ROE % Adjusted to Book Value is 0.00% as of Mar. 2025.

DIH Holding US's ROE % for the quarter that ended in Mar. 2025 was 0.00%. DIH Holding US's PB Ratio for the quarter that ended in Mar. 2025 was N/A. DIH Holding US's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 was N/A.

DIH Holding US ROE % Adjusted to Book Value Related Terms

DIH Holding US ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for DIH Holding US's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US ROE % Adjusted to Book Value Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DHAI vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, DIH Holding US's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DIH Holding US ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where DIH Holding US's ROE % Adjusted to Book Value falls into.


DIH Holding US ROE % Adjusted to Book Value Calculation

DIH Holding US's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

DIH Holding US's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
DIH Holding US (DHAI) has a ROE % Adjusted to Book Value of 0.00% as of Mar. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's ROE % Adjusted to Book Value too high?
DIH Holding US's current ROE % Adjusted to Book Value is 0.00%.
How does DIH Holding US's ROE % Adjusted to Book Value compare to ABT and SYK?
DIH Holding US's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DIH Holding US and its competitors. DIH Holding US's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For DIH Holding US (DHAI), the current ROE % Adjusted to Book Value is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.